AI assistant
Sending…
FATE THERAPEUTICS INC — Director's Dealing 2016
Nov 28, 2016
34091_dirs_2016-11-28_f0926c03-678a-4931-8087-efda6ebd6be9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2016-11-23
Reporting Person: RASTETTER WILLIAM H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-23 | Common Stock | P | 375939 | $2.66 | Acquired | 459272 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 118360 | Indirect |
Footnotes
F1: Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein.
F2: These shares are owned of record by The Investment 2002 Trust, dated November 11, 2002 for which William H. Rastetter is the sole trustee and owner.
F3: These shares are owned of record by The Rastetter Family Trust, dated September 2, 2010 for which William H. Rastetter and Marisa Gard Rastetter serve as co-trustees.
More from FATE THERAPEUTICS INC
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Proxy Solicitation & Information Statement
2026
Apr 24
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 16
Director's Dealing
2026
Jan 12
Director's Dealing
2026
Jan 12